Cargando…
Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study
Nanomedicines are a novel class of therapeutics that benefit from the nano dimensions of the drug carrier. These nanosystems are highly advantageous mainly within cancer treatment due to their enhanced tumor accumulation. Monolayer tumor cells frequently used in routine preclinical assessment of nan...
Autores principales: | Kudláčová, Júlia, Kotrchová, Lenka, Kostka, Libor, Randárová, Eva, Filipová, Marcela, Janoušková, Olga, Fang, Jun, Etrych, Tomáš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766879/ https://www.ncbi.nlm.nih.gov/pubmed/33419291 http://dx.doi.org/10.3390/pharmaceutics12121242 |
Ejemplares similares
-
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021) -
HPMA-Based Polymer Conjugates for Repurposed Drug Mebendazole and Other Imidazole-Based Therapeutics
por: Studenovský, Martin, et al.
Publicado: (2021) -
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo
por: Studenovský, Martin, et al.
Publicado: (2022) -
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
por: Tavares, Marina R., et al.
Publicado: (2021) -
Micelle-Forming Block Copolymers Tailored for Inhibition of P-gp-Mediated Multidrug Resistance: Structure to Activity Relationship
por: Braunová, Alena, et al.
Publicado: (2019)